Diacerein
- Generic Name
- Diacerein
- Drug Type
- Small Molecule
- Chemical Formula
- C19H12O8
- CAS Number
- 13739-02-1
- Unique Ingredient Identifier
- 4HU6J11EL5
Overview
Diacerein is a prodrug which is metabolized to rhein. It is currently approved in France for the treatment of osteoarthritis although the use of diacerein is restricted due to the side effects including severe diarrhea . Diacerein is under investigation for the treatment of Insulin Resistance, Diabetes Mellitus (Type 2), and Diabetes-Related Complications.
Background
Diacerein is a prodrug which is metabolized to rhein. It is currently approved in France for the treatment of osteoarthritis although the use of diacerein is restricted due to the side effects including severe diarrhea . Diacerein is under investigation for the treatment of Insulin Resistance, Diabetes Mellitus (Type 2), and Diabetes-Related Complications.
Indication
For the treatment of osteoarthritis affecting the hip or knee .
Associated Conditions
- Osteoarthritis in the Hip Joint
- Osteoarthritis of the Knee
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.